Literature DB >> 22926402

Overexpression of actin-depolymerizing factor blocks oxidized low-density lipoprotein-induced mouse brain microvascular endothelial cell barrier dysfunction.

Jun Wang1, Lu Sun, Yan-Fang Si, Bao-Min Li.   

Abstract

The aim of present work was to elucidate the role of actin-depolymerizing factor (ADF), an important regulator of actin cytoskeleton, in the oxidized low-density lipoprotein (ox-LDL)-induced blood-brain barrier (BBB) disruption. The primary mouse brain microvascular endothelial cells (MBMECs) were exposed to ox-LDL. Treatment with LDL served as control. It was found that ADF mRNA level and protein expression were decreased when exposed to ox-LDL in MBMECs. Then, we investigated the influence of ADF overexpression on ox-LDL-treated MBMECs. Structurally, overexpression of ADF inhibited ox-LDL-induced F-actin formation. Functionally, overexpression of ADF attenuated ox-LDL-induced disruption of endothelial barrier marked by restoration of transendothelial electrical resistance, permeability of Evans Blue and expression of tight junction-associated proteins including ZO-1 and occludin, and blocked ox-LDL-induced oxidative stress marked by inhibition of reactive oxygen species (ROS) formation and activity of NADPH oxidase and Nox2 expression. However, overexpression of ADF in control cells had no significant effect on endothelial permeability and ROS formation. In conclusion, overexpression of ADF blocks ox-LDL-induced disruption of endothelial barrier. In addition, siRNA-mediated downregulation of ADF expression aggravated ox-LDL-induced disruption of endothelial barrier and ROS formation. These findings identify ADF as a key signaling molecule in the regulation of BBB integrity and suggest that ADF might be used as a target to modulate diseases accompanied by ox-LDL-induced BBB compromise.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22926402     DOI： 10.1007/s11010-012-1415-7

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN： 0300-8177            Impact factor:   3.396


  33 in total

1.  Mildly oxidized low density lipoprotein induces contraction of human endothelial cells through activation of Rho/Rho kinase and inhibition of myosin light chain phosphatase.

Authors:  M Essler; M Retzer; M Bauer; J W Heemskerk; M Aepfelbacher; W Siess
Journal:  J Biol Chem       Date:  1999-10-22       Impact factor: 5.157

2.  CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.

Authors:  Eliseo A Eugenin; Kristin Osiecki; Lillie Lopez; Harris Goldstein; Tina M Calderon; Joan W Berman
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

3.  Oxidized low density lipoprotein-induced LFA-1-dependent adhesion and transendothelial migration of monocytes via the protein kinase C pathway.

Authors:  Shinichiro Mine; Takahiro Tabata; Youichiro Wada; Takeshi Fujisaki; Takeshi Iida; Noriko Noguchi; Etsuo Niki; Tatsuhiko Kodama; Yoshiya Tanaka
Journal:  Atherosclerosis       Date:  2002-02       Impact factor: 5.162

4.  Phallacidin prevents thrombin-induced increases in endothelial permeability to albumin.

Authors:  P G Phillips; H Lum; A B Malik; M F Tsan
Journal:  Am J Physiol       Date:  1989-09

5.  Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells.

Authors:  Yury I Miller; Suganya Viriyakosol; Christoph J Binder; James R Feramisco; Theo N Kirkland; Joseph L Witztum
Journal:  J Biol Chem       Date:  2002-11-06       Impact factor: 5.157

6.  Oxidized low-density lipoprotein induces apoptotic insults to mouse cerebral endothelial cells via a Bax-mitochondria-caspase protease pathway.

Authors:  Tyng-Guey Chen; Ta-Liang Chen; Huai-Chia Chang; Yu-Ting Tai; Yih-Giun Cherng; Ya-Ting Chang; Ruei-Ming Chen
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-06       Impact factor: 4.219

7.  oxLDL facilitates flow-induced realignment of aortic endothelial cells.

Authors:  Gregory B Kowalsky; Fitzroy J Byfield; Irena Levitan
Journal:  Am J Physiol Cell Physiol       Date:  2008-06-18       Impact factor: 4.249

8.  Effect of destrin mutations on the gene expression profile in vivo.

Authors:  Angela M Verdoni; Natsuyo Aoyama; Akihiro Ikeda; Sakae Ikeda
Journal:  Physiol Genomics       Date:  2008-04-01       Impact factor: 3.107

9.  Differential expression of proteins from cultured endothelial cells exposed to uremic versus normal serum.

Authors:  Carla Carbó; Gemma Arderiu; Ginés Escolar; Berta Fusté; Aleix Cases; Montserrat Carrascal; Joaquín Abián; Maribel Díaz-Ricart
Journal:  Am J Kidney Dis       Date:  2008-04       Impact factor: 8.860

10.  Role of the endothelial cytoskeleton in blood-brain-barrier permeability to protein.

Authors:  S Nag
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088
View more
  12 in total

Review 1.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 2.  Mechanisms of Blood Brain Barrier Disruption by Different Types of Bacteria, and Bacterial-Host Interactions Facilitate the Bacterial Pathogen Invading the Brain.

Authors:  Mazen M Jamil Al-Obaidi; Mohd Nasir Mohd Desa
Journal:  Cell Mol Neurobiol       Date:  2018-08-16       Impact factor: 5.046

3.  Activation of sonic hedgehog signaling attenuates oxidized low-density lipoprotein-stimulated brain microvascular endothelial cells dysfunction in vitro.

Authors:  Xiu-Long Jiang; Ting Chen; Xu Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  The role of actin depolymerizing factor in advanced glycation endproducts-induced impairment in mouse brain microvascular endothelial cells.

Authors:  Xinfeng Liu; Rongju Zhang; Hai Di; Dengfa Zhao; Jun Wang
Journal:  Mol Cell Biochem       Date:  2017-04-04       Impact factor: 3.396

Review 5.  New experimental models of the blood-brain barrier for CNS drug discovery.

Authors:  Mohammad A Kaisar; Ravi K Sajja; Shikha Prasad; Vinay V Abhyankar; Taylor Liles; Luca Cucullo
Journal:  Expert Opin Drug Discov       Date:  2016-11-07       Impact factor: 6.098

6.  LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention.

Authors:  H K Irundika Dias; Caroline L R Brown; M Cristina Polidori; Gregory Y H Lip; Helen R Griffiths
Journal:  Clin Sci (Lond)       Date:  2015-09-23       Impact factor: 6.124

7.  Cultured cells of the blood-brain barrier from apolipoprotein B-100 transgenic mice: effects of oxidized low-density lipoprotein treatment.

Authors:  Nikolett Lénárt; Fruzsina R Walter; Alexandra Bocsik; Petra Sántha; Melinda E Tóth; András Harazin; Andrea E Tóth; Csaba Vizler; Zsolt Török; Ana-Maria Pilbat; László Vígh; László G Puskás; Miklós Sántha; Mária A Deli
Journal:  Fluids Barriers CNS       Date:  2015-07-17

Review 8.  Triggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegeneration.

Authors:  Ana-Maria Enciu; Mihaela Gherghiceanu; Bogdan O Popescu
Journal:  Oxid Med Cell Longev       Date:  2013-03-07       Impact factor: 6.543

9.  The redox mechanism for vascular barrier dysfunction associated with metabolic disorders: Glutathionylation of Rac1 in endothelial cells.

Authors:  Jingyan Han; Robert M Weisbrod; Di Shao; Yosuke Watanabe; Xiaoyan Yin; Markus M Bachschmid; Francesca Seta; Yvonne M W Janssen-Heininger; Reiko Matsui; Mengwei Zang; Naomi M Hamburg; Richard A Cohen
Journal:  Redox Biol       Date:  2016-09-11       Impact factor: 11.799

Review 10.  Origin and pathophysiology of protein carbonylation, nitration and chlorination in age-related brain diseases and aging.

Authors:  Efstathios S Gonos; Marianna Kapetanou; Jolanta Sereikaite; Grzegorz Bartosz; Katarzyna Naparło; Michalina Grzesik; Izabela Sadowska-Bartosz
Journal:  Aging (Albany NY)       Date:  2018-05-17       Impact factor: 5.682
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.